Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma

Activating mutations involving the members of the RAS signaling pathway, including KRAS, NRAS, and BRAF, have been reported in ovarian low-grade serous carcinoma and its precursor lesion, serous borderline tumor (SBT). Whether additional genetic alterations in the RAS oncogene family accumulate duri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hum Pathol
Hauptverfasser: Xing, Deyin, Rahmanto, Yohan Suryo, Zeppernick, Felix, Hannibal, Charlotte G., Kjaer, Susanne K., Vang, Russell, Shih, Ie-Ming, Wang, Tian-Li
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696063/
https://ncbi.nlm.nih.gov/pubmed/28873354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.humpath.2017.08.021
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge